Search Results - "Durrer, P"

Refine Results
  1. 1

    Inflexal ® V—The influenza vaccine with the lowest ovalbumin content by Kürsteiner, O., Moser, C., Lazar, H., Durrer, P.

    Published in Vaccine (10-11-2006)
    “…The antigen used in influenza vaccines is directly derived from influenza viruses. It is produced in embryonated chicken eggs for both inactivated and live…”
    Get full text
    Journal Article
  2. 2

    Mucosal antibody response induced with a nasal virosome-based influenza vaccine by Durrer, P, Glück, U, Spyr, C, Lang, A.B, Zurbriggen, R, Herzog, C, Glück, R

    Published in Vaccine (01-10-2003)
    “…A vaccination against influenza that elicits both a systemic antibody and a mucosal IgA response would improve on the protective efficacy of currently…”
    Get full text
    Journal Article
  3. 3

    Photolabeling Identifies a Putative Fusion Domain in the Envelope Glycoprotein of Rabies and Vesicular Stomatitis Viruses by Durrer, Peter, Gaudin, Yves, Ruigrok, Rob W.H., Graf, Roland, Brunner, Josef

    Published in The Journal of biological chemistry (21-07-1995)
    “…Vesicular stomatitis and rabies viruses enter cells through receptor-mediated endocytosis, followed by fusion of the viral with the endosomal membrane. The…”
    Get full text
    Journal Article
  4. 4

    Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation by Gaudin, Y. (Laboratoire de genetique des virus du CNRS, Gif sur Yvette, France.), Tuffereau, C, Durrer, P, Flamand, A, Ruigrok, R.W.H

    Published in Journal of Virology (01-09-1995)
    “…The glycoprotein (G) of rabies virus can assume at least three different conformations: the native (N) state detected at the viral surface above pH 7; the…”
    Get full text
    Journal Article
  5. 5

    Inflexal super([registered]) V - The influenza vaccine with the lowest ovalbumin content by Kuersteiner, O, Moser, C, Lazar, H, Durrer, P

    Published in Vaccine (01-11-2006)
    “…The antigen used in influenza vaccines is directly derived from influenza viruses. It is produced in embryonated chicken eggs for both inactivated and live…”
    Get full text
    Journal Article
  6. 6

    Inflexal registered V-The influenza vaccine with the lowest ovalbumin content by Kuersteiner, O, Moser, C, Lazar, H, Durrer, P

    Published in Vaccine (01-11-2006)
    “…The antigen used in influenza vaccines is directly derived from influenza viruses. It is produced in embryonated chicken eggs for both inactivated and live…”
    Get full text
    Journal Article
  7. 7

    Membrane Interaction of Influenza Virus M1 Protein by Ruigrok, Rob W.H., Barge, Annie, Durrer, Peter, Brunner, Josef, Ma, Kai, Whittaker, Gary R.

    Published in Virology (New York, N.Y.) (15-02-2000)
    “…The M1 protein of influenza virus is thought to make contact with the cytoplasmic tails of the glycoprotein spikes, lipid molecules in the viral membrane, and…”
    Get full text
    Journal Article
  8. 8

    Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children by KANRA, GÜLER, MARCHISIO, PAOLA, FEITERNA-SPERLING, CORNELIA, GAEDICKE, GERHARD, LAZAR, HEDVIKA, DURRER, PETER, KÜRSTEINER, OLIVER, HERZOG, CHRISTIAN, KARA, ATES, PRINCIPI, NICOLA

    Published in The Pediatric infectious disease journal (01-04-2004)
    “…OBJECTIVE.To compare the immunogenicity and safety of a virosome-adjuvanted influenza vaccine (Inflexal V; Berna Biotech, Berne, Switzerland) and a split…”
    Get full text
    Journal Article
  9. 9

    Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial by Pfister, Markus, Kürsteiner, Oliver, Hilfiker, Helene, Favre, Didier, Durrer, Peter, Ennaji, Abdallah, L'Age-Stehr, Johanna, Kaufhold, Achim, Herzog, Christian

    “…BERNA-YF (Flavimun) is a live, attenuated yellow fever (YF) vaccine of the 17D strain produced by Berna Biotech Ltd. following a transfer of technology from…”
    Get more information
    Journal Article
  10. 10

    Safety and Immunogenicity of Intranasally Administered Inactivated Trivalent Virosome-Formulated Influenza Vaccine Containing Escherichia coli Heat-Labile Toxin as a Mucosal Adjuvant by Glück, Reinhard, Mischler, Robert, Durrer, Peter, Fürer, Emil, Lang, Alois B., Herzog, Christian, Cryz, Stanley J.

    Published in The Journal of infectious diseases (01-03-2000)
    “…A trivalent influenza virosome vaccine containing hemagglutinin and Escherichia coli heatlabile toxin (HLT) was administered intranasally to young adults and…”
    Get full text
    Journal Article
  11. 11

    H+-induced Membrane Insertion of Influenza Virus Hemagglutinin Involves the HA2 Amino-terminal Fusion Peptide but Not the Coiled Coil Region by Durrer, Peter, Galli, Carmela, Hoenke, Stefan, Corti, Chantal, Glück, Reinhard, Vorherr, Thomas, Brunner, Josef

    Published in The Journal of biological chemistry (07-06-1996)
    “…Fusion of influenza virus with target membranes is induced by acid and involves complex changes in the viral envelope protein hemagglutinin (HA). In a first,…”
    Get full text
    Journal Article
  12. 12

    A Conserved Motif in the Tail Domain of Vinculin Mediates Association with and Insertion into Acidic Phospholipid Bilayers by Johnson, Robert P, Niggli, Verena, Durrer, Peter, Craig, Susan W

    Published in Biochemistry (Easton) (14-07-1998)
    “…The tail domain of vinculin (Vt) contains a salt-insensitive binding site for acidic phospholipids which is masked by the intramolecular head−tail interaction…”
    Get full text
    Journal Article
  13. 13

    Open Randomized Trial Comparing the Immunogenicity and Safety of a New Measles-Mumps-Rubella Vaccine and a Licensed Vaccine in 12- to 24-Month-Old Children by Feiterna-Sperling, Cornelia, Brönnimann, Rainer, Tischer, Annedore, Stettler, Peter, Durrer, Peter, Gaedicke, Gerhard

    Published in The Pediatric infectious disease journal (01-12-2005)
    “…BACKGROUND:A trivalent measles-mumps-rubella (MMR) vaccine (MMR Berna) has been developed with a new mumps component, BBM-18, to replace a previously licensed…”
    Get full text
    Journal Article
  14. 14

    Intranasal Immunization with Mumps Virus DNA Vaccine Delivered by Influenza Virosomes Elicits Mucosal and Systemic Immunity by Cusi, Maria Grazia, Zurbriggen, Rinaldo, Valassina, Marcello, Bianchi, Silvia, Durrer, Peter, Valensin, Pier Egisto, Donati, Marco, Glück, Reinhard

    Published in Virology (New York, N.Y.) (10-11-2000)
    “…To improve the efficiency of liposome-mediated DNA transfer as a tool for gene therapy or vaccinology, we have further developed a new delivery system based on…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Membrane-mediated Release of Nucleotide from an Initiator of Chromosomal Replication, Escherichia coli DnaA, Occurs with Insertion of a Distinct Region of the Protein into the Lipid Bilayer by Garner, J, Durrer, P, Kitchen, J, Brunner, J, Crooke, E

    Published in The Journal of biological chemistry (27-02-1998)
    “…DnaA protein, the initiator protein of E. coli chromosomal replication, can be rejuvenated from an inactive ADP form to active ATP-DnaA protein by acidic…”
    Get full text
    Journal Article
  17. 17

    Intestinal Infection Due to Enteroaggregative Escherichia coli among Human Immunodeficiency Virus-Infected Persons by Durrer, Petra, Zbinden, Reinhard, Fleisch, Felix, Altwegg, Martin, Ledergerber, Bruno, Karch, Helge, Weber, Rainer

    Published in The Journal of infectious diseases (01-11-2000)
    “…To investigate the pathogenic role of enteroaggregative Escherichia coli (EAggEC) among human immunodeficiency virus-infected persons, 111 outpatients with and…”
    Get full text
    Journal Article
  18. 18

    Rabies virus-induced membrane fusion by Gaudin, Y, Tuffereau, C, Durrer, P, Brunner, J, Flamand, A, Ruigrok, R

    Published in Molecular membrane biology (01-01-1999)
    “…Rabies virus is a member of the rhabdovirus family. It enters cells by a process of receptor mediated endocytosis. Following this step, the viral envelope…”
    Get more information
    Journal Article
  19. 19

    Phenylarsine oxide stimulates pyridine nucleotide-linked Ca2+ release from rat liver mitochondria by Schweizer, M, Durrer, P, Richter, C

    Published in Biochemical pharmacology (30-08-1994)
    “…Rat liver mitochondria contain a specific Ca2+ release pathway which operates when oxidized mitochondrial pyridine nucleotides are hydrolysed to ADPribose and…”
    Get more information
    Journal Article
  20. 20

    H super(+)-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region by Durrer, P, Galli, C, Hoenke, S, Corti, C, Glueck, R, Vorherr, T, Brunner, J

    Published in The Journal of biological chemistry (01-01-1996)
    “…Fusion of influenza virus with target membranes is induced by acid and involves complex changes in the viral envelope protein hemagglutinin (HA). In a first,…”
    Get full text
    Journal Article